PT  - JOURNAL ARTICLE
AU  - Yoo, Hyun Joo
AU  - Nashiro, Kaoru
AU  - Dutt, Shubir
AU  - Min, Jungwon
AU  - Cho, Christine
AU  - Thayer, Julian F.
AU  - Lehrer, Paul
AU  - Chang, Catie
AU  - Mather, Mara
TI  - Daily biofeedback to modulate heart rate oscillations affects structural volume in hippocampal subregions targeted by the locus coeruleus in older adults but not younger adults
AID  - 10.1101/2023.03.02.23286715
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.03.02.23286715
4099  - http://medrxiv.org/content/early/2023/03/05/2023.03.02.23286715.short
4100  - http://medrxiv.org/content/early/2023/03/05/2023.03.02.23286715.full
AB  - Using data from a clinical trial, we tested the hypothesis that daily sessions modulating heart rate oscillations affect older adults’ volume of a region-of-interest (ROI) comprised of adjacent hippocampal subregions with relatively strong locus coeruleus (LC) noradrenergic input. Younger (N=106) and older adults (N=56) completed five weeks of heart rate variability biofeedback. Participants were randomly assigned to one of two daily biofeedback practices: 1) engage in slow-paced breathing (around 10-s per breath or 0.10 Hz) while receiving biofeedback to increase their heart rate oscillations (Osc+); 2) engage in self-selected strategies while receiving biofeedback to decrease their heart rate oscillations (Osc−). Biofeedback did not significantly affect younger adults’ hippocampal volume. Among older adults, the two biofeedback conditions affected volume in the LC-targeted hippocampal ROI differentially with the Osc+ condition showing relatively increased volume and Osc− showing relatively decreased volume. Older adults with greater average spectral power of heart rate at around 0.10 Hz during biofeedback sessions showed greater increases in volume across these regions.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT03458910Funding StatementThis study was supported by NIH R01AG057184 (PI Mather).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University of Southern California Institutional Review Board gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at OpenNeuro (https://openneuro.org/datasets/ds003823). https://openneuro.org/datasets/ds003823